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Abstract CHO SSF3 cells grow as a suspension culture in un- 
modified commercial medium with only low-molecular weight 
ingredients. Continuous erum-free culture unexpectedly induced 
expression of a low dihydrofolate reductase activity in the origi- 
nally dhfr- CHO cells. Nevertheless, it was possible with metho- 
trexate to induce amplification of a gene coding for the hybrid 
plasminogen activator K2tu-PA cotransfected with a dhfr gene. 
Expression of K2tu-PA expression was proportionally increased 
to that of dh)9, which was measured with fluorescent methotrex- 
ate. Because no serum proteases were present, secreted K2tu-PA 
was not converted to the enzymatically active form, but was 
exclusively recovered in proenzyme form. 
Key words: CHO cell; DHFR: Serum-free; Gene amplification: 
Plasminogen activator 
1. Introduction 
Chinese hamster ovary cells lacking the enzyme dihydro- 
folate reductase. CHO(dhfr ), are among the most frequently 
used recipient cells for stable transfection experiments. Cell 
lines, in which the recombinant dhfr gene together with cotrans- 
fected genes is amplified, are the basis of a very successful 
method to produce (glyco-)proteins in mammalian cells, which 
are then used for research purposes or as pharmaceutical prod- 
ucts [1--2]. The presence of serum in the conventional culture 
media complicates biological assay systems and is a negative 
determinant of the cost and quality of recombinant proteins 
[3,4]. Also ethical considerations press the scientific and indus- 
trial community to find ways to limit the slaughter of bovine 
fetuses for their serum. Hence, it is a great advantage to have 
cell lines which proliferate without proteinaceous growth fac- 
tors. The development of such cell lines requires both optimiza- 
tion of the composition of the low-molecular weight segment 
of the culture medium [5] and development of a cell line adapted 
to grow in this medium without addition of macromolecular 
growth factors [6]. 
Here, we describe the isolation of CHO cell variants adapted 
to grow in a commonly used, commercially available protein- 
free medium. As an example of its use, the production of the 
hybrid plasminogen activator K2tu-PA is given. This protein 
is currently investigated in a clinical trial as treatment for acute 
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myocardial infarction. It is composed of the Kringle-2 domain 
of human tissue-type plasminogen activator (t-PA) attached to 
the serine protease domain of the human urokinase-type las- 
minogen activator (u-PA) [7-11]. Like in the native plasmino- 
gen activators, proteolytic cleavage converts the otherwise inac- 
tive proenzyme K2tu-PA into an active plasrninogen activator. 
Unless protease inhibitors are added, this activation ofplasmin- 
ogen activators occurs spontaneously in serum-containing cell
cultures. The article focuses pecifically on expression of dhfr, 
the spontaneous reactivation of a silent dhfr gene in the serum- 
independent cell variants and on the amplification of dhJ?- 
linked genes in the new cell lines. 
2. Materials and methods 
2.1. Cell culture and DHFR assay 
Serum-dependent CHO(dhfr-) cells of strain DXB11, also referred 
to as DUKX, DUKXB1 or DUK-XB11 (a gift of Dr. L. Chasin), and 
CHO-K1 (ATCC CCL-61) were cultured with 4% fetal calf serum as 
previously described [11]. Lipofection of SSF3 cells with dhfr and K2tu- 
PA genes was done in DMEM/FI2 medium with 4% FCS as described 
previously [11,12]. Initial selection of transformants was done in media 
lacking lycine, hypoxantine and thymidine supplemented with 5 nM 
methotrexate (Sigma) and 4% dialyzed FCS. Selection for clones with 
increased dhfr expression was done by gradually increasing the metho- 
trexate concentration [11,12]. Cellular DHFR enzyme activity was as- 
sayed spectrophotometrically [13] or by FACS analysis of cells labeled 
with fluorescent methotrexate as described previously [14]. 
2.2. Protein analysis 
The amount of K2tu-PA in conditioned media was measured using 
an ELISA procedure with two monoclonal ntibodies recognizing the 
Kringle-2 domain of tissue-type plasminogen activator in the hybrid 
protein [7]. The cell number was determined using the hexoseaminidase 
method [15]. K2tu-PA was purified by immuno-affinity chromatogra- 
phy using monoclonal ntibody 405-B-33-3 [7]. The percentage single- 
chain K2tu-PA was analysed by polyacrylamide g l electrophoresis of 
the purified material. 
3. Results 
3.1. Choice of the culture medium 
The CHO(dhfr-) mutant DXB11 used in our experiments is 
derived from the proline-auxotrophic cellline CHO-K1 [16,17]. 
Hence, a proline-containing medium had to be chosen with 
additional supplements o compensate for the lack of the 
DHFR enzyme in the cells. DHFR catalyzes the reduction of 
folic acid to dihydrofolic acid and hence to tetrahydrofolic a id. 
In the absence of folate in the medium or in the absence of 
intracellular DHFR activity, cells exhibit a requirement for 
glycine, a purine and thymidine. The purine requirement is 
usually satisfied with hypoxanthine or adenine. In our labora- 
tory, DXBI 1 are grown in alpha-MEM medium supplemented 
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Fig. l. DHFR expression i different CHO cell lines. The dhfr CHO 
cell line DXB11 was isolated after mutagenesis fir t with ethyl methane 
sulfonate (EMS), creating the intermediate h mizygous UKB25 line 
followed by treatment with gamma radiation [16,21]. From DXB 11, the 
different SSF lines were derived with or without EMS mutagenesis by 
selection (Sel.) for growth in protein-free medium. SSF3 cultures were 
tested for DHFR activity as described insection 2after being cultured 
for 30 or 60 passages in protein-free medium. At passage 60, a SSF3 
subline termed SSF8 was isolated, which was tested 9passages later. 
with ribo- and deoxyribonucleosides (Life Sciences) and 4% 
FCS. The alpha-MEM medium is very rich in essential and 
non-essential amino acids and contains 40 mg/l proline and 50 
mg/l glycine. The glycine plus the added nucleosides allow dhji" 
cells to grow. The dhj? phenotype of DXBI 1 appears to be 
stable over at least 20 passages in this medium as judged from 
the lack of 'background colonies" in dh h" transfection experi- 
ments. It was not possible to isolate clones of CHO(dhfr-) cells, 
which would grow in serum-free alpha-MEM. Hence. DMEM/ 
FI2 medium was used instead. It contains compared with 
alpha-MEM many additional components. The glycine, hy- 
poxanthine and thymidine content are 18.75 mg/l, 2.39 mg/] and 
0.365 mg/l, respectively. Hence, DMEM/FI2 is expected to be 
non-selective with respect o the dh/k-status of the cells. 
3.2. Isolation and cultivathm q[serum-independent CHO cel/,~ 
Isolation of cell lines, which grow in DMEM/F12 medium 
completely devoid of macromolecular components, i  schemat- 
ically shown in Fig. 1. One series of cell lines, of which SSF6 
is typical, was obtained by ethyl methanesulfonate (EMS) mut- 
agenesis of DXBll cells followed by selection in protein-free 
DMEM/F12, whereby 30% of the medium was replaced 2-3 x 
per week. A second series of cell lines, including SSF3 and its 
derivatives, were obtained by the same method, but without 
prior EMS mutagenesis. Using either method, it took 6 8 weeks 
before extensive proliferation of the cells could be detected. 
Both the SSF3 line and the SSF6 line have since been cultured 
for more than a year under protein-free conditions. Precisely. 
because it was never subjected to deliberate mutagenesis, most 
of our gene expression experiments have been done with the 
SSF3 line. 
The protein-independent phenotype of the SSF cells appears 
to be stable. SSF3 cells grown for 4 months in DMEM/FI2 with 
4% serum could be re-adapted toprotein-free medium without 
any apparent lag in cell growth rate. When standard CHO cells 
(dhJr or dhJi "+) were similarly placed in serum-free medium, 
alter 3~4 days the cells gradually started to die to the extent that 
< 10% of the initial cells were viable after a week. The prolifer- 
ation rate of SSF cells in DMEM/F12 is close to that of the 
parental DXB11 cells in medium with serum (specific growth 
rate,/~ = 1.1 d -1 [18,19]). The actual specific growth rate of 
SSF3 ranged from 0.38 d -l at low density to 0.9 d -1 at high cell 
concentrations. This dependence of the proliferation rate on the 
density at which the cells are seeded was lost when 30% condi- 
tioned medium of SSF3 cells was added to the medium. Stimu- 
lation of the growth of DXB11 cells in SSF cell-conditioned 
medium also suggest hat the SSF cells produce (dialyzable) 
growth-promoting substances [18]. 
3.3. SSF cells grow as suspension cultures 
When grown in protein-free medium, SSF cells did not ad- 
here stably to the plastic of standard tissue culture dishes. After 
being subcultured in fresh medium, the cells attached tran- 
siently, but did not spread out. However, 2 or 3 days after 
subculturing all the SSF cells detached from the plastic and 
proliferated even in the absence of stirring as a suspension 
culture. This detachment from the growth substrate may ex- 
plain why serum-independent CHO cells have not been isolated 
much earlier. After addition of serum, SSF cells attached rap- 
idly to the growth substrate and, once spread out, were in the 
light microscope morphologically indistinguishable from the 
parental CHO(dhfr-) cells. Therefore, the 'non-adherent- 
growth' phenotype of the SSF cells is probably not the direct 
result of a genetic hange of the cells. Apparently, the SSF cells 
and presumably also the parental CHO cells do not make suf- 
ficient adherence proteins to adhere to the growth substrate in 
absence of factors normally added with the serum. That the 
SSF cells do not attach to a growth substrate in absence of 
serum proteins, is an advantage in large scale cultures, as the 
SSF cells do not cling to the interior surface of bioreactors, nor 
do they obstruct he surface of in-line detection devices. 
3.4. Reactivation of  a silent endogenous dhfr gene in SSF  cells 
Although, SSF cells have never been exposed eliberately to
dhfr-selective conditions, we discovered that most of the cell 
lines, especially those cultured longer under protein-free condi- 
tion, continued to grow when transferred to selection medium 
(Fig. 2). The growth difference in selective and non-selective 
medium disappeared when cells were plated at high cell density. 
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Fig. 2. Growth of serum-independent c ll lines under DHFR-selective 
conditions. Comparison of the growth of SSF3 in T-flasks at passage 
27 (A) and 82 (B) in medium containing lycine, hypoxanthine and 
thymidine (closed symbols) or dhfr-selective medium without these 
compounds (open symbols). Subcultures were initiated at three differ- 
ent cell densities. 
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Fig. 3. FACS analysis of DHFR expression i  transfected wild-type and 
serum-independent CHO cells. The intracellular DHFR was visualized 
by labeling the cells with FITC-methotrexate. Addition of an excess ( 1 
,uM) of non-fluorescent methotrexate suppressed fluorescence of SSF3 
and CHO-K1 to the level of dhj?- DXB11 cells (not shown), but had 
no effect on DXB11 fluorescence. (A- B) Comparison of different cell 
lines discussed in the text. 
This suggests that a transfer of nutrients occurs from the dh/r- 
expressing cells to those lacking dhfi'. The presence of DHFR 
enzyme activity in SSF cells could also be demonstrated by a 
spectrophotometric assay (Fig. 1) and could be inhibited com- 
pletely with methotrexate. By this assay, later passages of SSF3 
cells expressed about 10 times more DHFR enzyme activity 
than the dhfi'- CHO(dhfr ) parent cells and approximately 10 
times less DHFR than wild-type CHO-K1 cells. By limited 
dilution cloning, sublines could been isolated of the SSF3 cell 
line with a very low percentage of dhfi "+ cells. However, these 
lines always slowly reverted to a dh& + phenotype during pro- 
longed culture under protein-free conditions. That growth 
under selection conditions was due to expression of a genuine 
DHFR enzyme could also be demonstrated by FACS analysis 
of cells treated with a fluorescent derivative of the DHFR 
inhibitor methotrexate [20]. SSF3 cells displayed a fluorescence 
intensity midway (on the logarithmic scale!) between that of 
standard CHO(dhfr-) cells and the wild-type parent cell line of 
CHO(dhfr-) cells. CHO-KI  (Fig. 3A). 
3.5. Adaptation o]the dh/? selection procedure.fbr SSF3-derived 
cell lines 
Because SSF3 cells express already some DHFR activity, 
culture conditions had to be found which would discriminate 
between untransfected cells with only this endogenous DHFR 
activity and dhfr-transfected cells with a higher activity. When 
hypoxanthine, thymidine and glycine was omitted from the 
medium, the bulk of untransfected SSF3 cells ceased to grow, 
but in mock transfection/selection experiments many apparent 
dhJ~ + colonies were still obtained. When also 5 nM methotrex- 
ate was included, the dh[r + colonies not containing a transfected 
dhfr gene were eliminated. The relationship between transfec- 
tion efficiency and methotrexate concentration is shown in 
Fig. 4. At methotrexate concentrations higher than 5 nM, the 
selection behavior of the SSF3 cell line was not significantly 
different from that of the parental CHO(dhfr ) cell line. DXB 11 
(Fig. 4). 
The approach described above was used to isolate clones 
transfected with pCGA72PCRK2, a plasmid combining a dh/i 
gene with a gene coding for the hybrid plasminogen activator 
K2tu-PA [11]. Only the transfection and the first 2 weeks of 
culture in Petri dishes were done in selective medium with 4% 
dialyzed FCS. Protein-flee medium was used once the clones 
of transfected cells had been transferred into microwells (2 
weeks after transfection). Essentially, all clones picked (90 out 
of 96) continued to grow when placed in protein-free medium. 
About 50% of these clones also expressed plasminogen activa- 
tor. 
3.6. Amplification o/dhfr-linked K2tu-PA gene in SSF3 cells 
Twelve K2tu-PA-producing clones, identified by ELISA [7] 
were subjected to selection in stepwise increasing concentra- 
tions of methotrexate. Of these, in at least six the production 
of the plasminogen activator was increased significantly after 
rnethotrexate s lection. Measured by FACS analysis, the initial 
pCGA72aPCRK2 transformants expressed DHFR levels com- 
parable to CHO-K1, which increased further after selection in 
100 nM methotrexate (cell line 10/10, Fig. 3B). After selection 
using gradually methotrexate concentration, the expression of 
K2tu-PA increased in parallel to the increase of dhfr expression 
(Fig. 5). 
3.7. SSF3 cells produce single-chain recombinant plasminogen 
activator 
Alter activation in vitro with plasmin, no significant differ- 
ence was seen in the specific enzymatic activity between purified 
SSF3-derived K2tu-PA and material derived from transfected 
standard CHO(dhfr-) cells [8-10]. However, 20-60% of the 
K2tu-PA from the conditioned medium of transfected 
CHO(dhfr ) cells (if cultured without addition of protease in- 
hibitors) was found to be in the two-chain form and was already 
enzymatically active prior to deliberate activation with plasmin. 
In contrast, this was the case for less than 3% of K2tu-PA from 
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Fig. 4. Transfection efficiency and methotrexate r sistance of SSF3 
cells. Formation of dhfr + colonies at different methotrexate concentra- 
tions after transfection of DXBll and SSF3 cells with pCGA65e, a 
plasmid with dhfr in an SV40 'early' expression cassette [11]. The 
number of dt~fr +colonies obtained in selective medium without metho- 
trexate (100% values) were 500 ___ 20 and 800 + 50 (n = 4) for DXB11 
and SSF3, respectively. With SSF3, but not with DXBI 1 also dhfr + 
colonies were obtained in a mock transfection experiment (600 + 100 
colonies, not subtracted from percentile values). Results are expressed 
(A) as a percentage of the number of colonies obtained in wselective 
medium without methotrexate or (B) expressed as percentage of the 
number of colonies obtained with 5 nM methotrexate. Note that above 
5 nM there is effectively no contribution from the endogenous DHFR 
activity in the SSF3 cell line as the two curves practically coincide 
(panel B). 
(2. Gandor et aL/FEBS Letters 377 ,1995,, 290 294 293 
600 
500 
400 
300 
200 
100 
0 
:luorescence (units) OD405 (ELISA) 
100nM ~ ~ " ~t  i 20o o:! 
N O" SSF3 12 12.9 12.9.5 12.9.19 
Cell Lines 
DHFR (FACS) ~ K2tu-PA (ELISA) 
Fig. 5. Correlation between dhfr and K2tu-PA expression during ampli- 
fication in serum-independent CHO cell lines. Comparison of expres- 
sion of dhJr and K2tu-PA in SSF3 cells and four cell lines transfected 
with pCGA72aPCRK2 [11] all derived from clone 12, which were se- 
lected to grow in different concentrations of methotrexate (concentra- 
tion indicated in nM above the bars). 
transfected SSF3 cells, whereby 3% is the lower detection limit 
of the method used. 
4. Discussion 
4.1. Possible mechanisms (~[ reversmn ~f the dlTf) ~ genoO'pe 
In the creation of the CHO(dhfr ) cell line from CHO-K1 
[16], both functional dhfi" alleles were sequentially inactivated 
(Fig. 1). The first allele was inactivated creating the hemizygous 
line UKB25 from which in turn DXBI I was isolated [21]. As 
the results above show, for at least one of the genes inactivation 
is not irreversible. This is most likely the allele already inac- 
tivated in UKB25, because it was isolated after mutagenesis 
with ethyl methane sulfonate, a base substitution mutagen. The 
second allele was inactivated after gamma radiation, which is 
more likely to have induced an irreversible deletion. As DXB11 
is the most commonly used CHO(dhfr ) mutant [1], it is impor- 
tant to be aware of the possibility of reactivation of the dh/i" 
gene. DG-44, another dhfr- CHO cell line, more stable but not 
as widely used, appears to have lost both DHFR alleles by 
deletions [22]. 
4.2. A connection between dhfi" d~fhciency and serum 
requiremen t?
It is not entirely clear why, even when 10 mg/l of all four 
ribo-and deoxyribonucleosides are supplied, dhfr- CHO ceils 
should still revert o dhj?- under protein-free conditions. Possi- 
bly, dhji-deficient CHO cells require besides the nucleic acid 
precursors another intermediate metabolite which is supplied 
by the serum in standard media. This hypothesis is supported 
by observations made while testing batches of dialyzed serum 
used in standard dhJ? selections. When the non-selective me- 
dium was supplemented with dialyzed serum, the proliferation 
rate of the CHO(dhfr-) cells was always slightly reduced com- 
pared with that observed with complete serum. In contrast, for 
the parental dhJV CHO-KI  or CHO(dhfr ) cells, which had 
been transfected with a DHFR gene, the growth-promoting 
activity of the dialyzed serum batches was equal and often 
better than with undialyzed serum. Possibly, the results ob- 
tained with the SSF cells are due to the absence of this/these 
metabolite(s) associated with the low-molecular weight serum 
fraction in the protein-free medium. One candidate for the 
unidentified substance would be N-formyl-methionine eded 
to initiate mitochondrial protein synthesis, which normally is 
synthesized via a DHFR-dependent pathway. 
4.3. Prospects for animal cell culture in protein-free media 
Elimination of serum as biological variable greatly facilitates 
development of more economic production processes, The ab- 
sence of serum proteins eases purification of the recombinant 
proteins and avoids degradation of the recombinant product by 
serum proteases. The absence of two-chain K2tu-PA is a good 
example of the latter. Incidentally, these results probably ex- 
clude proteases released from the CHO cells themselves as the 
cause of formation two-chain plasminogen activator in CHO 
cell production systems. It was not necessary to use protease 
inhibitors in the medium or to include an additional purifica- 
tion step to eliminate the enzyrnatically active form. The highest 
levels of production of this and other recombinant proteins 
obtained with stably transfected SSF3-derived cell lines were, 
like observed with the parental CHO(dhfr-)-derived cells, 
around 20 50/zg per 10 6 cells day -1 or 2-5 10 t4 molecules cell -1 
day ~ [23]. The availability of procedures to manipulate mam- 
malian cells genetically in the absence of serum also opens the 
possibility of using these cells for other experiments han pro- 
duction of recombinant proteins, where serum-containing me- 
dium would interfere, for example in assays of signal transduc- 
tion by hormones naturally present in serum. 
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